Distinct Site-specific Oncoprotein Overexpression in Head and Neck Squamous Cell Carcinoma: A Tissue Microarray Analysis

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3971-3977

  Freier, Kolja ^a,b   Bosch, Franz X ^b   Flechtenmacher, Christa ^b   Devens, Frauke ^a   Benner, Axel ^a   Lichter, Peter ^a   Joos, Stefan ^a   Hofele, Christof ^b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Head and neck squamous cell carcinoma (HNSCC); Immunohistochemistry (IHC); Oncoprotein overexpression; Tissue microarray (TMA); Tumor classification

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MYC PROTEIN; ONCOPROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FREQUENCY ANALYSIS; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROANALYSIS; MOUTH CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 0345305234     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kononen J, Bubendorf L, Kalloniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G and Kalloniemi O-P: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 4: 844-847, 1998.
2. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackerman D, Mauer R, Alund G, Knönagel H et al: High-throughput tissue microarrayanalysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 154: 981-996, 2000.
3. Moch H, Schraml P, Bibendorf L, Mirlacher M, Kononen J, Gasser T and Mihatsch MJ: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154(4): 981-6, 1999.
4. Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U et al: Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194(3): 349-57, 2001.
5. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP and Sauter G: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159(6): 2249-56, 2001.
6. Landis SH, Murray T, Bolden S and Wingo PA: Cancer statistics. CA Cancer J Clin 49: 8-31, 1999.
7. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W and Sidransky D: Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56: 2488-2492, 1996.
8. Michalides RJ, van Veelen NM, Kristel PM, Hart AA, Loftus BM, Hilgers FJ and Balm AJ: Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123(5): 497-502, 1997.
9. Schoelch ML, Regezi JA, Dekker NP, Ng IO, McMillan A, Ziober BL, Le QT, Silverman S and Fu KK: Cell cycle proteins and the development of oral squamous cell carcinoma Oral Oncol 35(3): 333-42, 1999.
10. Akervall J, Borg A, Dictor M, Jin C, Jin Y, Tanner M, Isola J, Mertens F and Wennerberg J: Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 20(1): 45-52, 2002.
11. Carlos de Vicente J, Herrero-Zapatero A, Fresno MF and Lopez-Arranz JS: Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 38(3): 301-8, 2002.
12. Rousseau A, Lim MS, Lin Z and Jordan RC: Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias Oral Oncol 37(3): 268-75, 2001.
13. Rodrigo JP, Lazo PS, Ramos S, Alvarez I and Suarez C: C-MYC amplification in squamous cell carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg 122(5): 504-7, 1996.
14. Eversole LR and Sapp JP: c-c-Myc oncoprotein expression in oral precancerous and early cancerous lesions. Eur J Cancer B Oral Oncol 29B(2): 131-5, 1993.
15. Beckhardt RN, Kiyokawa N, Xi L, Liu TJ, Hung MC, el-Naggar AK, Zhang HZ and Clayman GL: HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 121(11): 1265-70, 1995.
16. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G and Slamon DJ: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17(9): 2639-48, 1999.
17. Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K and Stell PM: C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 12(3): 613-9, 1992.
18. Craven JM, Pavelic ZP, Stambrook PJ, Pavelic L, Gapany M, Kelley DJ, Gapany S and Gluckman JL: Expression of c-erbB2 gene in human head and neck carcinoma. Anticancer Res 12(6B): 2273-6, 1992.
19. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D and Haffty BG: Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 8(2): 540-8, 2002.
20. Etienne MC, Pivot X, Formento JL, Bensadoun RJ, Formento P, Dassonville O, Francoual M, Poissonnet G, Fontana X, Schneider M, Demard F and Milano G: A multifactorial approach including tumoral epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil. Br J Cancer 79(11-12): 1864-9, 1999.
21. Rikimaru K, Tadokoro K, Yamamoto T, Enomoto S and Tsuchida N: Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. Head Neck 14(1): 8-13, 1992.
22. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O and Demard F: Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13(2): 132-9, 1991.
23. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F and Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11(10): 1873-8, 1993.
24. Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, Huang CJ, Kandaswami C, Middleton E Jr and Lee MT: Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128(5): 999-1010, 1999.
25. Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksal H, Mendelsohn J and Hong WK: Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res 7(5): 1204-13, 2001.
26. Ford AC and Grandis JR: Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 25(1): 67-73, 2003.
27. Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P and Hofele C: Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63(6): 1179-82, 2003.
28. Kyomoto R, Kumazawa H, Toda Y, Sakaida N, Okamura A, Iwanaga M, Shintaku M, Yamashita T, Hiai H and Fukumoto M: Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer 74(6): 576-81, 1997.
29. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J and Van Krieken JH: Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res 18(6B): 4793-800, 1998.
30. Bei R, Pompa G, Vitolo D, Moriconi E, Ciocci L, Quaranta M, Frati L, Kraus MH and Muraro R: Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma. J Pathol 195(3): 343-8, 2001.
31. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Quatela M, Cesana BM and Pignataro L: Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes. Head Neck 22(3): 234-40, 2000.
32. Baatenburg de Jong RJ, Knegt P and Verwoerd CD: Reduction of the number of neck treatments in patients with head and neck cancer. Cancer 71(7): 2312-8, 1993.
33. Batsakis JG: Tumors of the Head and Neck. (Williams and Wlikins) Baltimore, 1979.
34. Takes RP, Baatenburg de Jong RJ, Wijffels K, Schuuring E, Litvinov SV, Hermans J and van Krieken JH: Expression of genetic markers in lymph node metastases compared with their primary tumors in head and neck cancer. J Pathol 194(3): 298-302, 2001.
35. Gapany M, Pavelic ZP, Kelley DJ, Pavelic L, Gapany SR, Craven JM, Stambrook PJ and Gluckman JL: Immunohistochemical detection of c-c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck Surg 120(3): 255-9, 1994.
36. Field JK, Spandidos DA, Stell PM, Vaughan ED, Evan GI and Moore J: Elevated expression of the c-c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 4(12): 1463-8, 1989.
37. Putti TC, To KF, Hsu HC, Chan AT, Lai GM, Tse G, Lee YS, Whang-Peng J, Millward M, Lin L, Lin X and Lee CS: Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region. Histopathology 41(2): 144-51, 2002.
38. Azemar M, Schmidt M, Arlt F, Kennel P, Brandt B, Papadimitriou A, Groner B and Wels W: Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo. Int J Cancer 86(2): 269-75, 2000.
39. Li M, Ye C, Feng C, Riedel F, Liu X, Zeng Q and Grandis JR: Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Clin Cancer Res 8(11): 3570-8, 2002.
40. Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S and Budillon A: Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. J Cell Physiol 195(1): 139-50, 2003.
41. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K, Harada H, Wennerberg J and Dictor M: Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 36(2): 194-8, 2003.
42. Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A and de la Hoz C: p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113(1):167-72, 2003.
43. Gaffey MJ, Iezzoni JC, Meredith SD, Boyd JC, Stoler MH, Weiss LM, Zukerberg LR, Levine PA, Arnold A and Williams ME: Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Hum Pathol 26(11): 1221-6, 1995.
44. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, Li L, Katz RL and Hung MC: Combination of EGFR/ERBB1, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5(12): 4164-74, 1999.
45. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62(24): 7350-6, 2002.
46. Poetsch M, Kleist B, Lorenz G and Herrmann FH: Different numerical chromosomal aberrations detected by FISH in oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. Histopathology 34(3):234-40, 1999.
47. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H and Bosch FX: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58(1): 5-13, 1998.
48. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R and Schantz SP: Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34(2): 224-33, 2002.